Assumptions for the AUC were identified, including the fact that all indications assumed a first-time transthoracic echocardiographic study in an outpatient setting for patients without previously known heart disease. The definitions for frequently used terminology in outpatient pediatric cardiology were established using published guidelines and standards and expert opinion. These AUC serve as a guide to help clinicians in the care of children with possible heart disease, specifically in terms of when a transthoracic echocardiogram is warranted as an initial diagnostic modality in the outpatient setting. They are infrastructure for future quality improvement initiatives as well as research in healthcare delivery, outcomes, and resource utilization.
To complete the AUC process, the writing group identified 113 indications based on common clinical scenarios and/or published clinical practice guidelines, and each indication was classified into 1 of 9 categories of common clinical presentations, including palpitations, syncope, chest pain, and murmur. A separate, independent rating panel evaluated each indication using a scoring scale of 1 to 9, thereby designating each indication as "Appropriate"
(median score 7 to 9), "May Be Appropriate" (median score 4 to 6), or "Rarely Appropriate" (median score 1 to 3). Fifty-three indications were identified as Appropriate, 28 as May Be Appropriate, and 32 as Rarely Appropriate.
PREFACE
In an effort to respond to the need for the rational use of services in the delivery of high quality care, the ACC has undertaken a process to determine the appropriate use of cardiovascular imaging and procedures for selected patient indications.
AUC publications reflect an ongoing effort by the ACC to critically and systematically create, review, and categorize clinical situations where diagnostic tests and procedures are utilized by physicians caring for patients with known or suspected cardiovascular diseases. The process is based on current understanding of the technical capabilities of the imaging modalities and procedures examined. Although not intended to be entirely comprehensive due to the wide diversity of clinical disease, the indications are meant to identify common scenarios encountered by the majority of contemporary practices.
Given the breadth of information they convey, the indications do not directly correspond to the International Classification of Diseases (ICD) system. The ACC believes that careful blending of a broad range of clinical experiences and available evidence-based information will help guide a more efficient and equitable allocation of health care resources in cardiovascular imaging.
The ultimate objective of AUC is to improve patient care and health outcomes in a cost-effective manner, but they are not intended to ignore ambiguity and nuance intrinsic to clinical decision-making. Local parameters, such as the availability or quality of equipment or personnel, may influence the selection of certain tests or procedures. AUC thus should not be considered substitutes for sound clinical judgment and practice experience.
INTRODUCTION

Improvements in cardiovascular imaging technologies
and their application, particularly with increasing therapeutic options for cardiovascular disease, have led to an increase in the utilization of such technologies. As these imaging technologies and clinical applications continue to advance, the healthcare community needs to understand how best to incorporate these options into daily clinical care and how to choose between new and long-standing, established imaging technologies. In an effort to respond to this need and to ensure the effective use of advanced diagnostic imaging tools and procedures, the AUC project was initiated. The AUC in this document have been developed in order to promote effective patient care, better clinical outcomes, and improved resource utilization. This set of AUC should be useful not only for pediatric cardiologists, but also for general pediatricians and family practitioners, who are frequently the first clinicians to consider the need for this modality.
Although AUC have been established for echocardiography in adult patients (1) (2) (3) , a similar document for pediatric patients has not yet been published. This is partly because the scope of such a document would require an impossibly extensive list, if criteria were developed for each congenital cardiac malformation and its variants before and after intervention. Guidelines and standards for performing a pediatric echocardiogram, as well as recommendations for quantification methods, have already been published (4, 5) . However, the questions often raised by AUC of "when to do" and "how often to do" a pediatric echocardiogram still remained.
To address these concerns, the American College of Cardiology initiated an AUC document on pediatric echocardiography in the outpatient setting, since outpatient care is an important component of clinical pediatric cardiology. Children with heart disease represent a widely varied group of patients, frequently characterized by complex anatomic malformations requiring lifelong follow-up. While echocardiography is the primary diagnostic modality for children with established congenital and acquired heart disease, the scope of the current document has been limited to first-time outpatient transthoracic echocardiographic studies in patients without previously known cardiac abnormalities. This narrower set of clinical presentations has been chosen because of the high volume of such testing within pediatric cardiology. In addition, this initiative has established the infrastructure to develop additional AUC for pediatric and congenital echocardiography in other settings.
METHODS
This document covers a wide array of potential signs and symptoms associated with cardiovascular disease in pediatric patients. A standardized approach was used to create different categories of indications with the goal of capturing actual clinical scenarios, without making the list of indications excessively long. Indications were created to represent most of the possible uses of echocardiography in the outpatient pediatric setting rather than limiting the AUC to indications for which evidence was available.
To identify and categorize the indications, a writing group of pediatric echocardiography experts was formed of representatives from a variety of organizations and societies. Wherever possible during the writing process, the group members would map the indications to relevant clinical guidelines and key publications or references (See Online Appendix). Once the indications were formed, they were reviewed and critiqued by the parent AUC Task Force and numerous external reviewers representing all pediatric cardiovascular specialties and primary care. After the writing group incorporated this initial feedback, the indications were sent to an independent rating panel comprised of additional experts in the pediatrics and pediatric cardiology realm, before being sent back to the writing group for additional vetting.
Each indication was then rated and classified as either "Appropriate care", "M a yB eA p p r o p r i a t ec a r e ",o r "Rarely Appropriate care" based on these multiple rounds of review and revision (see Figure 1) . intermediate level of appropriate use should be labeled "May Be Appropriate," as critical patient or research data may be lacking or discordant. This designation should be a prompt to the field to carry out definitive research investigation whenever possible. It is anticipated that the AUC reports will continue to be revised as further data are generated and information from criteria implementation is accumulated.
To prevent bias in the scoring process, the rating panel, by design, included a minority of specialists in pediatric echocardiography. Specialists, while offering important clinical and technical insights, might have a natural tendency to rate the indications within their specialty as more appropriate than non-specialists. In addition, care was taken to provide objective, nonbiased information, including guidelines and key references, to the rating panel. 4. The use of transesophageal or stress echocardiography will not be addressed in this document.
5. This document assumes that any other more definitive diagnostic test, including but not limited to electrocardiogram (ECG), chest X-ray, or genetic testing, when appropriate will be considered prior to ordering a TTE.
6. All standard TTE techniques for image acquisition are available for each indication and have a sensitivity Criteria for "abnormal ECG" will be based upon stan- (2) 2.
Palpitations with no other symptoms or signs of cardiovascular disease, a benign family history, and a normal ECG R (1) 3.
Palpitations with abnormal ECG M (6) 4.
Palpitations with family history of a channelopathy R (3)
5.
Palpitations in a patient with known channelopathy M (4) 6. Palpitations with family history at a young age (before the age of 50 years) of sudden cardiac arrest or death and/or pacemaker or implantable defibrillator placement A (7) 7.
Palpitations with family history of cardiomyopathy A (9) 8. Palpitations in a patient with known cardiomyopathy A (9)
ECG Findings
9.
PACs in the prenatal or neonatal period R (3) 10.
PACs after the neonatal period R
11. Supraventricular tachycardia A (7) 12. PVCs in the prenatal or neonatal period M (6) 13. PVCs after the neonatal period M (6) 14. Ventricular tachycardia A (9) 15. Sinus bradycardia R (2) 16.
Sinus arrhythmia R (1)
The number in parentheses next to the rating reflects the median score for that indication. 
25.
Exertional syncope A (9) 26. Unexplained post-exertional syncope A (7) 27. Syncope or pre-syncope with a known non-cardiovascular cause R (2)
The number in parenthesis next to the rating reflects the median score for that indication. 
40.
Presumptively innocent murmur with signs, symptoms, or findings of cardiovascular disease A (7)
Pathologic murmur A (9)
42.
Symptoms and/or signs suggestive of congestive heart failure, including but not limited to respiratory distress, poor peripheral pulses, feeding difficulty, decreased urine output, edema, and/or hepatomegaly A (9) 43. Chest wall deformities and scoliosis pre-operatively M (6)
44.
Fatigue with no other signs and symptoms of cardiovascular disease, a normal ECG, and a benign family history R (3)
45.
Signs and symptoms of endocarditis in the absence of blood culture data or a negative blood culture A (8) 46. Unexplained fever without other evidence for cardiovascular or systemic involvement M (5) 47. Central cyanosis A (8)
Isolated acrocyanosis R (1)
32.
Non-exertional chest pain with normal ECG R (1)
33.
Non-exertional chest pain with abnormal ECG A (7) 34.
Chest pain with family history of sudden unexplained death or cardiomyopathy A (8) 35.
Chest pain with family history of premature coronary artery disease M (4) 36.
Chest pain with recent onset of fever M (6) 37. Reproducible chest pain with palpation or deep inspiration R (1)
Chest pain with recent illicit drug use M (6)
The number in parenthesis next to the rating reflects the median score for that indication. 67. Clinically suspected syndrome or extracardiac congenital anomaly known to be associated with congenital heart disease A (9)
Human immunodeficiency virus infection A (8)
Suspected or confirmed Kawasaki disease
A (9) 70. Suspected or confirmed Takayasu arteritis A (9) 71. Suspected or confirmed acute rheumatic fever A (9) 72. Systemic lupus erythematosis and autoimmune disorders A (7) 73. Muscular dystrophy A (9) 74. Systemic hypertension A (9) 75. Renal failure A (7) 76. Obesity without other cardiovascular risk factors R 
Abnormalities of visceral or cardiac situs A (9)
The number in parenthesis next to the rating reflects the median score for that indication.
Abbreviations: A ¼ Appropriate; M ¼ May Be Appropriate; R ¼ Rarely Appropriate. 
50.
Genotype positive for cardiomyopathy A (9) 51. Abnormal chest X-ray findings suggestive of cardiovascular disease A (9) 52. Abnormal ECG without symptoms A (7) 53. Desaturation based on pulse oximetry A (9) 54. Previously normal echocardiogram with no change in cardiovascular status or family history R (1) 55.
Previously normal echocardiogram with a change in cardiovascular status and/or a new family history suggestive of heritable heart disease A (7) 56. Elevated anti-streptolysin O titers without suspicion for rheumatic fever R (3) 57.
Chromosomal abnormality known to be associated with cardiovascular disease A (9) 58. Chromosomal abnormality with undefined risk for cardiovascular disease M (5) 59.
Positive blood cultures suggestive of infective endocarditis A (9) 60. Abnormal cardiac biomarkers A (9) 61. Abnormal barium swallow or bronchoscopy suggesting vascular ring A (7) The number in parenthesis next to the rating reflects the median score for that indication. (6) 90. Premature coronary artery disease before the age of 50 years R (2) 91. Channelopathy R (3) 92.
Hypertrophic cardiomyopathy A (9) 93. Non-ischemic dilated cardiomyopathy A (9) 94.
Other cardiomyopathies A (8) 95. Unspecified cardiovascular disease R (3) 96. Disease at high risk for cardiovascular involvement, including but not limited to diabetes, systemic hypertension, obesity, stroke, and peripheral vascular disease R (2) 97. Genetic disorder at high risk for cardiovascular involvement A (7) 98. Marfan or Loeys Dietz syndrome A (7) 99.
Connective tissue disorder other than Marfan or Loeys Dietz syndrome M (6) 100. Congenital left-sided heart lesion, including but not limited to mitral stenosis, left ventricular outflow tract obstruction, bicuspid aortic valve, aortic coarctation, and/or hypoplastic left heart syndrome M (6) 101.
Congenital heart disease other than the congenital left-sided heart lesions M (5) 102. Idiopathic pulmonary arterial hypertension M (5) 103. Heritable pulmonary arterial hypertension A (8) 104. Pulmonary arterial hypertension other than idiopathic and heritable R (3) 105. Consanguinity
Abbreviations: A ¼ Appropriate; M ¼ May Be Appropriate; R ¼ Rarely Appropriate. (9) 107. Isolated echogenic focus on fetal ultrasound R (2) 108. Maternal infection during pregnancy or delivery with potential fetal/neonatal cardiac sequelae A (7) 109. Maternal diabetes with no prior fetal echocardiogram M (6) 110. Maternal diabetes with a normal fetal echocardiogram M (4) 111. Maternal phenylketonuria A (7) 112. Maternal autoimmune disorder M (5) 113.
Maternal teratogen exposure M (6)
Abbreviations: A ¼ Appropriate; M ¼ May Be Appropriate; R ¼ Rarely Appropriate.
FLOW DIAGRAMS FOR COMMON PATIENT SYMPTOMS
FIGURE 3 Chest Pain
Each indication is preceded with a number sign. The rating of A, M, or R is then followed by the median score in parenthesis for that particular indication. *See Discussion section. Abbreviations: A ¼ Appropriate; M ¼ May Be Appropriate; R ¼ Rarely Appropriate; ECG ¼ Electrocardiogram.
FIGURE 4 Syncope
Each indication is preceded with a number sign. The rating of A, M, or R is then followed by the median score in parenthesis for that particular indication. AUC for Pediatric Echocardiography -,2 0 1 4 : ---
FIGURE 5 Palpitations and Arrhythmias
Each indication is preceded with a number sign. The rating of A, M, or R is then followed by the median score in parenthesis for that particular indication. *See 
FIGURE 6 Murmur
Each indication is preceded with a number sign. The rating of A, M, or R is then followed by the median score in parenthesis for that particular indication.
Abbreviations: A ¼ Appropriate; M ¼ May Be Appropriate; R ¼ Rarely Appropriate. The definitions provided in this document were finalized by the writing group after it had given due consideration to the current literature and views provided by the external reviewers and the rating panel. The users of this document should be well versed in these assumptions and definitions prior to implementing the AUC.
Indications and Ratings
The indications presented in this report were finalized (21, 31) . Echocardiographic screening for presumably or clearly innocent murmur has been rated as Rarely Appropriate in this document. This rating is supported by prior publications reporting that examination by a pediatric cardiologist is quite accurate in distinguishing between innocent and pathologic murmurs (21, 32, 33) . Pathologic murmurs (including those that are not clearly innocent after evaluation), along with presumably innocent murmurs with other signs, symptoms or findings of cardiovascular disease, were found to be Appropriate for an echocardiogram, since these situations suggest the possibility of a cardiovascular abnormality as their underlying cause. Of course, the ability to make a final diagnosis of innocent murmur after an echocardiogram for patients meeting either of these appropriate indications does not imply that the rationale for using an echocardiogram to rule out a cardiovascular abnormality was not appropriate.
Chest pain and syncope are 2 other common presentations in the pediatric age group. The etiology for these is generally benign and echocardiography has been shown to be low-yield, unlike in adult patients (25) (26) (27) (28) (29) . (34, 35) . This current report for pediatric patients has certainly benefited from the maturational process and experience gained by the AUC in adults (36) . Implementation studies in the pediatric population will help us to identify any missing or ambiguous indications that could be addressed in future revisions.
In comparing the ratings of various indications in the current document with those in the adult AUC, there were many indications that were rated similarly (3).
For example, isolated PACs and sinus bradycardia were rated as Rarely Appropriate indications in both documents, while SVT, VT, pathologic murmurs, initial evaluation of suspected pulmonary hypertension, systemic hypertension, and suspected endocarditis were rated as Appropriate in both. However, there were some striking differences in the ratings of some indications such as syncope and chest pain due to variations in the most common underlying causes in pediatric versus adult patients.
There are also differences in format. In this report, p r i o rt e s tr e s u l t sf o rw h i c has u b s e q u e n te c h o c a r d i o g r a m may be ordered are listed separately in Table 7 with individual ratings; but in the adult AUC report they are lumped together under one indication ('Prior testing that is concerning for heart disease or structural abnormality including but not limited to chest X-ray, baseline scout images for stress echocardiogram, ECG, or cardiac biomarkers' (3)), and are rated as Appropriate.
The current report also includes a broad list of systemic disorders ( Table 7 ) and scenarios related to family history ( Table 8 ) that are not covered in the adult AUC report.
Limitations
The 
Use of AUC to Improve Care
We foresee several important applications of these AUC in the pediatric population. The most obvious use of this document will be to support the clinical decision making of a provider as to the appropriateness of care that they deliver to an individual pediatric patient. 
CONCLUSIONS
This AUC report provides a helpful guide to clinicians in determining the reasonable role of initial transthoracic echocardiography in the evaluation of pediatric patients in an outpatient setting. It also lays the foundation for developing AUC in other areas of pediatric cardiology.
Furthermore, it can form the basis of designing educational and quality improvement projects to improve quality of care. Future studies to evaluate implementation of these AUC in clinical care will be helpful not only in identifying any deficiencies in the current document, but also in defining ordering patterns for individual practitioners and understanding variations in delivery of care. We expect that there will be a continued need for refinement of these AUC based on any gaps identified through this initial effort, changes in evidence-based medicine, and availability of technical and financial resources. 
